Aegerion Pharmaceuticals, Inc. Securities Litigation
On or around 02/21/2017 (Other)
Filing Date: August 16, 2016
According to a law firm's press release, on June 14, 2016, Aegerion’s Board of Directors (the “Board”) caused the Company to enter into an agreement and plan of merger (the “Merger Agreement”). Pursuant to the terms of the Merger Agreement, each outstanding share of Aegerion common stock will be exchanged for 1.0256 shares of Parent common stock. The Complaint alleges that on August 8, 2016, Defendants issued materially incomplete and misleading disclosures in the Form S-4 Registration Statement (the “Registration Statement”) filed with the United States Securities and Exchange Commission (“SEC”) in connection with the Proposed Transaction. The Registration Statement is deficient and misleading in that it fails to provide adequate disclosure of all material information related to the Proposed Transaction.
This case was voluntarily dismissed on December 27, 2016.
Company & Securities Information
Defendant: Aegerion Pharmaceuticals, Inc.
Industry: Biotechnology & Drugs
Headquarters: United States
Ticker Symbol: AEGR
Company Market: NASDAQ
Market Status: Public (Listed)
About the Company & Securities Data
"Company" information provides the industry and sector classification and headquarters state for the primary company-defendant in the litigation. In general, "Securities" information provides the ticker symbol, market, and market status for the underlying securities at issue in the litigation.
In most cases, the primary company-defendant actually issued the securities that are the subject of the litigation, and the securities information and company information relate to the same entity. In a small subset of cases, however, the primary company-defendant is not the issuer (for example, cases against third party brokers/dealers), and the securities information and company information do not relate to the same entity.
First Identified Complaint
Chaile Steinberg, et al. v. Aegerion Pharmaceuticals, Inc., et al.
COURT: D. Massachusetts
DOCKET #: 16-CV-11668
JUDGE: Hon. George A. OToole, Jr
DATE FILED: 08/16/2016
CLASS PERIOD START: 06/15/2016
CLASS PERIOD END: 08/16/2016
PLAINTIFF FIRMS NAMED IN COMPLAINT:
Matorin Law Office, LLC 18 Grove Street, Suite 5, Matorin Law Office, LLC, MA 02482 (781) 453-0100 ·
First Identified Complaint (FIC) Filings:
Complaint For Violation Of Sections 14(A) And 20(A) of the Securities Exchange Act of 1934
Stipulation And Order Dismissing Action And Reserving Jurisdiction For Plaintiff's Counsel's Application For An Award Of Attorneys' Fees & Reimbursement Of Expenses